Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-034141

Adamas Pharmaceuticals Inc · ADMS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
MDV VII LP
10% Owner
MDV IX LP
10% Owner
Period of report
Apr 10, 2015
Accepted (ET)
Apr 14, 2015 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001328143

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Apr 10, 2015S37,078$18.557D462,527IMDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF
Common StockF4holding———3,772,686IMDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP
Common StockF4holding———265,150IMDV VII, L.P.
Common StockF4holding———6,043IMDV ENF VII (A), L.P.
Common StockF4holding———3,146IMDV ENF VII (B), L.P.
Common StockF4holding———25,661IMDV VII Leaders' Fund, L.P.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses